Search News Archives
Follow us on
Conferences | Events
Lab Bulletin Media Partners
Kerafast

Kerafast

Kerafast

Products

Contact Kerafast


If you have not logged into the website then please enter your details below.

All articles from Kerafast

  Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community....

 

  Kerafast Celebrates 5 Years of Facilitating Access to Research Reagents

Start-up company now partners with 140+ prominent research institutions

kerafast logoKerafast Inc., developers of an industry-leading online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, is celebrating its five-year anniversary this December. Since its founding in December 2011, Kerafast has partnered with more than 140 prominent academic institutions to facilitate access to research tools....

 

  Kerafast Expands List of International Providing Institutions

Key partners add to growing list of academic institutions making reagents available

KerafastKerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, today announced an increase in the number of international institutional laboratories adding reagents and services to its catalog....

 

  Kerafast adds new Zika virus antibody to its catalog of novel life science reagents

Company aims to help accelerate progress toward a vaccine or treatment for this global health threat

Anti-Zika Virus Envelope (E) Protein AntibodyKerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced the availability of a Zika virus antibody from Vanderbilt University. While researchers scramble to increase the pace of research toward treatment and prevention measures for the Zika virus, the virus’s geographical distribution continues to widen during this epidemic.

 

  Kerafast Partners with the National Cancer Institute (NCI) - Enables Sharing of NCI Research Materials through Kerafast Platform

Partnership seeks to advance scientific discovery by offering important bioreagents

Kerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from academic and government laboratories across the globe, today announced an agreement to make important research materials from the National Cancer Institute available through Kerafast’s platform. With this agreement, Kerafast has now partnered with 122  institutes....